Skip to main content

Table 2 DMARD use in idiopathic and JIA uveitis

From: Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry

Drug

Idiopathic Uveitis

JIA Uveitis

N = 92 (%)

N = 643 (%)

Methotrexate

70 (76)

549 (85)

 Oral

44 (48)

375 (58)

 SQ

46 (50)

416 (65)

Mycophenolate mofetil

9 (10)

33 (5)

Cyclosporine

3 (3)

20 (3)

Sulfasalazine

1 (1)

47 (7)

Hydroxychloroquine

0 (0)

27 (4)

Leflunomide

0 (0)

20 (3)

Tacrolimus

0 (0)

8 (1)

Azathioprine

0 (0)

3 (0.4)

Cyclophosphamide

0 (0)

1 (0.2)

  1. Data in this table represent “ever drug use” in patients with data available on DMARD drug exposure (92/92 patients with idiopathic uveitis and 643/646 patients with JIA uveitis)
  2. JIA juvenile idiopathic arthritis, SQ subcutaneous
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096